Header cover image

German (DAX) Pharma Industry Analysis

UpdatedSep 26, 2025
DataAggregated Company Financials
Companies12
  • 7D-1.1%
  • 3M-3.5%
  • 1Y-25.3%
  • YTD-9.2%

Over the last 7 days, the Pharma industry has dropped 1.1%, driven by a pullback from Merck KGaA of 1.2%. Overall the industry is down 25% in 12 months. Earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the German Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Sep 2025€75.9b€68.8b-€438,193,727.7018x-173.2x1.1x
Sun, 24 Aug 2025€79.9b€68.9b-€409,723,954.9217.5x-195.1x1.2x
Tue, 22 Jul 2025€77.7b€69.4b-€283,071,598.0017.3x-274.5x1.1x
Thu, 19 Jun 2025€76.9b€69.4b-€206,268,848.0017.5x-372.8x1.1x
Sat, 17 May 2025€74.7b€69.4b-€206,564,479.0017.7x-361.7x1.1x
Mon, 14 Apr 2025€72.5b€69.3b€467.0m17.7x155.2x1x
Wed, 12 Mar 2025€84.2b€69.2b€436.0m21x193.2x1.2x
Fri, 07 Feb 2025€85.4b€69.2b€2.0b22.9x42.1x1.2x
Sun, 05 Jan 2025€82.3b€69.2b€2.0b22.6x41x1.2x
Tue, 03 Dec 2024€83.1b€69.2b€2.0b21.1x41x1.2x
Thu, 31 Oct 2024€92.5b€69.4b€1.6b19.5x59.3x1.3x
Sat, 28 Sep 2024€102.1b€69.4b€1.5b24.6x69.3x1.5x
Mon, 26 Aug 2024€104.4b€69.3b€1.5b31.2x71.6x1.5x
Wed, 24 Jul 2024€95.4b€69.2b-€303,627,757.0029.2x-314.2x1.4x
Fri, 21 Jun 2024€100.6b€69.2b-€328,028,608.0026.6x-306.6x1.5x
Sun, 19 May 2024€103.4b€69.2b-€318,587,180.0021.7x-324.5x1.5x
Tue, 16 Apr 2024€94.6b€70.0b-€34,208,180.0020.6x-2764.1x1.4x
Thu, 14 Mar 2024€98.1b€70.0b€6.5m20.1x15100.7x1.4x
Sat, 10 Feb 2024€96.1b€70.6b-€650,504,143.0019.8x-147.8x1.4x
Mon, 08 Jan 2024€99.2b€70.6b-€650,504,143.0020x-152.5x1.4x
Wed, 06 Dec 2023€104.2b€70.6b-€650,606,256.0018.9x-160.2x1.5x
Fri, 03 Nov 2023€105.5b€72.1b€4.7b18x22.6x1.5x
Sun, 01 Oct 2023€116.1b€72.1b€4.7b22x24.8x1.6x
Tue, 29 Aug 2023€123.2b€72.1b€4.7b22.9x26.4x1.7x
Thu, 27 Jul 2023€122.3b€74.1b€6.5b18.9x19x1.6x
Sat, 24 Jun 2023€119.2b€74.2b€6.4b18.5x18.5x1.6x
Mon, 22 May 2023€129.1b€74.0b€6.4b22.3x20.3x1.7x
Wed, 19 Apr 2023€134.3b€74.2b€7.6b19.5x17.6x1.8x
Fri, 17 Mar 2023€130.0b€74.2b€7.7b17.5x17x1.8x
Sun, 12 Feb 2023€140.7b€72.8b€8.4b15.3x16.8x1.9x
Tue, 10 Jan 2023€137.6b€72.8b€8.4b15.1x16.4x1.9x
Thu, 08 Dec 2022€130.1b€72.8b€8.4b16.3x15.5x1.8x
Sat, 05 Nov 2022€127.0b€70.5b€7.8b13x16.4x1.8x
Mon, 03 Oct 2022€121.6b€70.5b€7.8b13x15.7x1.7x
Price to Earnings Ratio

15.7x


Total Market Cap: €121.6bTotal Earnings: €7.8bTotal Revenue: €70.5bTotal Market Cap vs Earnings and Revenue0%0%0%
German Pharma Industry Price to Earnings3Y Average 139.2x202320242025
Current Industry PE
  • Investors are pessimistic on the German Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market-1.06%
Healthcare-2.76%
Pharma-1.13%
Pharma-1.13%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PSG PharmaSGP Holding€30.804.1%
+€13.8m
n/aPE18x
HIGH Cantourage Group€3.8910.2%
+€4.5m
-26.6%PE611.8x